Clinical trial
To Compare the Effect of Liraglutide When Given Together With Metformin With the…
NCT00318461 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00318461 |
|---|---|
| Title | To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together |
| Official title | Liraglutide Effect and Action in Diabetes (LEAD-2): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Metformin Versus Metformin Monotherapy Versus Metformin and Glimepiride Combination Therapy in Subjects With Type 2 Diabetes |
| Acronym | LEAD-2 |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | liraglutide, metformin, glimepiride, placebo |
| Enrollment | 1,091 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Apr 26, 2006 |
| Last update posted | Mar 7, 2017 |
| Countries | Argentina, Australia, Belgium, Bulgaria, Croatia, Denmark, Germany, Hungary, India, Ireland, Italy, Netherlands and 8 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: